Denis Ullrich

Denis Ullrich specialises in advising on the sale and purchase of companies and shares in companies (M&A), the incorporation of companies and the reorganisation of companies and groups. His work also includes restructuring and crisis transactions. His clients include medium-sized companies, international groups and strategic investors from various branches as well as private equity companies and entrepreneurs within the framework of succession planning. Furthermore, Denis Ullrich advises shareholders, management board members, managing directors, supervisory boards and advisory councils on all matters pertaining to corporate law.

Corporate/M&A
Restructuring & Insolvency
Start-ups & Venture Capital

Denis Ullrich studied law majoring in economics at the University of Bayreuth (Germany). He joined Luther in 2005.

• The Legal 500 Germany 2023: Recommended in "Industry Focus - Health" (first listed in 2020, "Denis Ullrich is a very competent and committed colleague who was available to me as a technically experienced contact in many matters from corporate law to pharmaceutical law and gave me valuable support in my work. In all joint projects, we have always been able to develop economically sensible and goal-oriented solutions for our company.") and in "City Focus Leipzig"
• The Legal 500 Germany 2019: Listed in "Restructuring and Insolvency - Restructuring"

• Pharmaceutical Group: Sale of a business unit including international pharmaceutical approvals
• Labelprint 24 Group: Advising on the sale of the company group to All4Labels Global Group / Triton
• IDT Biologika GmbH: Advising on the sale of the animal health division to Ceva Sante Animale
• Puraglobe Holding GmbH: advice on the sale of Baufeld Chemie GmbH and the light oil separator division to Remondis
• Shareholder of i2s Intelligente Sensorsysteme Dresden GmbH: Advising on the sale of the company to Amphenol Corporation
• Shareholder of Chainmaster Bühnentechnik GmbH: advice on the sale of the company to Liftket Hofmann GmbH / AFINUM
• Shareholder of Data Information Intelligence GmbH: Advising on the sale of the company to The Economist Intelligence Group
• Pharmaceutical Group: Advice on the acquisition of a production facility in Germany

• 01.03.2013: Health-Claims-Verordnung – Das regulatorische Umfeld für die Lebensmittelwerbung nach Inkrafttreten der Art. 13 Liste
• 01.12.2012: Kreatives Werben mit Health Claims

• 24.02.2010: Rechte und Pflichten des Prokuristen, Fachverlag der Verlagsgruppe Handelsblatt GmbH, WSF Wirtschaftsseminare
• 12.08.2009: Rechte und Pflichten des Prokuristen, Fachverlag der Verlagsgruppe Handelsblatt GmbH, WSF Wirtschaftsseminare